News
12-17-2016, 09:50 PM
Ribociclib significantly improves progression-free survival in Asian women with advanced breast cancer, according to a sub-analysis of the MONALEESA-2 trial presented at the ESMO Asia 2016 Congress in Singapore.
More... (http://www.news-medical.net/news/20161217/Combined-endocrine-and-targeted-therapy-could-be-effective-in-treating-Asian-breast-cancer-patients.aspx)
More... (http://www.news-medical.net/news/20161217/Combined-endocrine-and-targeted-therapy-could-be-effective-in-treating-Asian-breast-cancer-patients.aspx)